Using UNC's expertise to fight emerging diseases

Posted Jul 13, 2018
Gilead Sciences, Inc., and Carolina are teaming up to save lives. The biopharmaceutical company sought the University's resources and talents in the development of treatments to control disease outbreaks. Imagine: One drug with the potential to treat MERS, SARS, Ebola, and the common cold. At Carolina, researchers are imagining — and enabling — just that. (UNC.edu)

Related: Campus Connections

There Will Never Be Another Stuart Scott
For an entire generation of American sports fans, Stuart Scott loomed as large as the superstar athletes he covered. After 22 years at ESPN—bringing a...
Sun Dec 14, 2025

Meet UNC's Winter Commencement Graduates
After dedicating years to their studies, 1,444 Tar Heels will receive their Carolina diplomas at Winter Commencement on Sunday. UNC's December graduates excelled in the...
Sat Dec 13, 2025

Chansky’s Notebook: Game Changer
“Boo-Yah” to the Carolina guy who popularized the word. ESPN’s 30 for 30 special on Stuart Scott will make you laugh and wonder how he...
Thu Dec 11, 2025

Beyond Boo-Yah: How Stuart Scott’s friends carry his memory to this day
What comes to mind when you hear the name Stuart Scott? For Roy Williams, it’s as simple as a smile. "That’s the best thing...that’s a...
Wed Dec 10, 2025